Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Controlling bovine leukemia virus in dairy herds by identifying and removing cows with the highest proviral load and lymphocyte counts.

Ruggiero VJ, Norby B, Benitez OJ, Hutchinson H, Sporer KRB, Droscha C, Swenson CL, Bartlett PC.

J Dairy Sci. 2019 Oct;102(10):9165-9175. doi: 10.3168/jds.2018-16186. Epub 2019 Aug 1.

2.

Control of Bovine Leukemia Virus in Three US Dairy Herds by Culling ELISA-Positive Cows.

Ruggiero VJ, Bartlett PC.

Vet Med Int. 2019 Jun 25;2019:3202184. doi: 10.1155/2019/3202184. eCollection 2019.

3.

Chemical composition and enzyme inhibition of Phytolacca dioica L. seeds extracts.

Di Petrillo A, María González-Paramás A, Rosa A, Ruggiero V, Boylan F, Kumar A, Pintus F, Santos-Buelga C, Fais A, Era B.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):519-527. doi: 10.1080/14756366.2018.1563077.

4.

Alexithymia and sense of coherence: Does their impact on fibromyalgia suggest new targets for therapy?

Sancassiani F, Preti A, Cacace E, Ruggiero V, Testa G, Romano F, Carta MG.

Gen Hosp Psychiatry. 2019 Jul - Aug;59:78-79. doi: 10.1016/j.genhosppsych.2018.12.001. Epub 2018 Dec 6. No abstract available.

PMID:
30638611
5.

Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?

Mela Q, Ruggiero V, Montaldo L, Pisano U, Matta L, Maria Pasetto C, Onali S, Cacace E, Carta MG, Barca L, Chessa L.

HIV Clin Trials. 2018 Oct;19(5):188-196. doi: 10.1080/15284336.2018.1525841. Epub 2018 Nov 16.

PMID:
30445888
6.

The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life.

Carta MG, Moro MF, Pinna FL, Testa G, Cacace E, Ruggiero V, Piras M, Romano F, Minerba L, Machado S, Freire RC, Nardi AE, Sancassiani F.

Int J Soc Psychiatry. 2018 Nov;64(7):647-655. doi: 10.1177/0020764018795211. Epub 2018 Aug 27.

PMID:
30146928
7.

On-site detection of bovine leukemia virus by a field-deployable automatic nucleic extraction plus insulated isothermal polymerase chain reaction system.

Ruggiero VJ, Benitez OJ, Tsai YL, Lee PA, Tsai CF, Lin YC, Chang HG, Wang HT, Bartlett P.

J Virol Methods. 2018 Sep;259:116-121. doi: 10.1016/j.jviromet.2018.06.008. Epub 2018 Jun 11.

8.

The management of fibromyalgia from a psychosomatic perspective: an overview.

Sancassiani F, Machado S, Ruggiero V, Cacace E, Carmassi C, Gesi C, Dell'Osso L, Carta MG.

Int Rev Psychiatry. 2017 Oct;29(5):473-488. doi: 10.1080/09540261.2017.1320982. Epub 2017 Jul 6. Review.

PMID:
28681628
9.

Free amino acids in fibromyalgia syndrome: relationship with clinical picture.

Ruggiero V, Mura M, Cacace E, Era B, Peri M, Sanna G, Fais A.

Scand J Clin Lab Invest. 2017 Apr;77(2):93-97. doi: 10.1080/00365513.2016.1269362. Epub 2017 Jan 12.

PMID:
28079404
10.

Plasma phospholipase, γ-CEHC and antioxidant capacity in fibromyalgia.

Fais A, Cacace E, Atzori L, Era B, Ruggiero V.

Int J Rheum Dis. 2017 May;20(5):550-554. doi: 10.1111/1756-185X.12787. Epub 2015 Nov 20.

PMID:
26585319
11.

High-Resolution DCE-MRI of the Pituitary Gland Using Radial k-Space Acquisition with Compressed Sensing Reconstruction.

Rossi Espagnet MC, Bangiyev L, Haber M, Block KT, Babb J, Ruggiero V, Boada F, Gonen O, Fatterpekar GM.

AJNR Am J Neuroradiol. 2015 Aug;36(8):1444-9. doi: 10.3174/ajnr.A4324. Epub 2015 May 7.

12.

Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia.

Caboni P, Liori B, Kumar A, Santoru ML, Asthana S, Pieroni E, Fais A, Era B, Cacace E, Ruggiero V, Atzori L.

PLoS One. 2014 Sep 19;9(9):e107626. doi: 10.1371/journal.pone.0107626. eCollection 2014.

13.

A preliminary study on serum proteomics in fibromyalgia syndrome.

Ruggiero V, Era B, Cacace E, Molin L, Corda M, Fais A, Utzeri S.

Clin Chem Lab Med. 2014 Sep;52(9):e207-10. doi: 10.1515/cclm-2014-0086. No abstract available.

PMID:
24698824
14.

Breath tests with novel 13C-substrates for clinical studies of liver mitochondrial function in health and disease.

Grattagliano I, Bonfrate L, Oliveira PJ, Castorani L, Ruggiero V, Valenzano AT, Ascensão A, Buzoianu A, Portincasa P.

Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:72-81. Review.

15.

Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.

Loiarro M, Volpe E, Ruggiero V, Gallo G, Furlan R, Maiorino C, Battistini L, Sette C.

J Biol Chem. 2013 Oct 18;288(42):30210-22. doi: 10.1074/jbc.M113.490946. Epub 2013 Sep 9.

16.

The Use of Antidepressants in the Long-Term Treatment Should not Improve the Impact of Fibromyalgia on Quality of Life.

Carta M, Ruggiero V, Sancassiani F, Cutrano F, Manca A, Peri M, Fais A, Cacace E.

Clin Pract Epidemiol Ment Health. 2013 Jul 12;9:120-4. doi: 10.2174/1745017901309010120. eCollection 2013.

17.

Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.

Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P.

Clin Pharmacol Ther. 2014 Jan;95(1):89-97. doi: 10.1038/clpt.2013.148. Epub 2013 Jul 18. Review. Erratum in: Clin Pharmacol Ther. 2014 Jan;95(1):110.

PMID:
23867542
18.

Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.

Zullo A, Scaccianoce G, De Francesco V, Ruggiero V, D'Ambrosio P, Castorani L, Bonfrate L, Vannella L, Hassan C, Portincasa P.

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):647-50. doi: 10.1016/j.clinre.2013.04.003. Epub 2013 Jun 6.

PMID:
23747131
19.

Targeting the Toll-like receptor/interleukin 1 receptor pathway in human diseases: rational design of MyD88 inhibitors.

Loiarro M, Ruggiero V, Sette C.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):222-6. doi: 10.1016/j.clml.2013.02.003. Epub 2013 Mar 13. Review.

PMID:
23490990
20.

Purine metabolites in fibromyalgia syndrome.

Fais A, Cacace E, Corda M, Era B, Peri M, Utzeri S, Ruggiero V.

Clin Biochem. 2013 Jan;46(1-2):37-9. doi: 10.1016/j.clinbiochem.2012.09.009. Epub 2012 Sep 18.

PMID:
23000315
21.
22.

Salmonella typhimurium DT104 in farmed rabbits.

Borrelli L, Fioretti A, Ruggiero V, Santaniello A, Cringoli G, Ricci A, Barco L, Menna LF, Dipineto L.

J Vet Med Sci. 2011 Mar;73(3):385-7. Epub 2010 Oct 28.

23.

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

Capolunghi F, Rosado MM, Cascioli S, Girolami E, Bordasco S, Vivarelli M, Ruggiero B, Cortis E, Insalaco A, Fantò N, Gallo G, Nucera E, Loiarro M, Sette C, De Santis R, Carsetti R, Ruggiero V.

Rheumatology (Oxford). 2010 Dec;49(12):2281-9. doi: 10.1093/rheumatology/keq226. Epub 2010 Aug 25.

PMID:
20739362
24.

Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression.

Loiarro M, Campo S, Arseni B, Rossi S, D'Alessio V, De Santis R, Sette C, Ruggiero V.

Prostate. 2011 Jan 1;71(1):32-41. doi: 10.1002/pros.21219.

PMID:
20607765
25.

Targeting TLR/IL-1R signalling in human diseases.

Loiarro M, Ruggiero V, Sette C.

Mediators Inflamm. 2010;2010:674363. doi: 10.1155/2010/674363. Epub 2010 Apr 8. Review.

26.

Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.

Loiarro M, Gallo G, Fantò N, De Santis R, Carminati P, Ruggiero V, Sette C.

J Biol Chem. 2009 Oct 9;284(41):28093-103. doi: 10.1074/jbc.M109.004465. Epub 2009 Aug 13.

27.

The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency.

Lindstedt R, Ruggiero V, D' Alessio V, Manganello S, Petronzelli F, Stasi MA, Vendetti S, Assandri A, Carminati P, De Santis R.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):29-42.

PMID:
19309550
28.

Efficacy of a nanocochleate-encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease.

Campo S, Arseni B, Rossi S, D'Alessio V, Lu R, Ngoje J, Ahl PL, Bonitz S, Mannino R, Di Mitri D, Battistini L, Carminati P, De Santis R, Ruggiero V.

Transplantation. 2008 Jul 15;86(1):171-5. doi: 10.1097/TP.0b013e31817ba761.

PMID:
18622296
29.

Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88.

Fantò N, Gallo G, Ciacci A, Semproni M, Vignola D, Quaglia M, Bombardi V, Mastroianni D, Zibella MP, Basile G, Sassano M, Ruggiero V, De Santis R, Carminati P.

J Med Chem. 2008 Mar 13;51(5):1189-202. doi: 10.1021/jm070723u. Epub 2008 Feb 15.

PMID:
18275134
30.

Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atherosclerosis.

Brunetti ND, Munno I, Pellegrino PL, Ruggiero V, Correale M, Cuculo A, De Gennaro L, Campanale G, Mavilio G, Ziccardi L, Di Biase M.

J Interv Cardiol. 2007 Aug;20(4):248-57.

PMID:
17680854
31.

ARDSnet ventilatory protocol and alveolar hyperinflation: role of positive end-expiratory pressure.

Grasso S, Stripoli T, De Michele M, Bruno F, Moschetta M, Angelelli G, Munno I, Ruggiero V, Anaclerio R, Cafarelli A, Driessen B, Fiore T.

Am J Respir Crit Care Med. 2007 Oct 15;176(8):761-7. Epub 2007 Jul 26.

PMID:
17656676
32.

Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.

Loiarro M, Capolunghi F, Fantò N, Gallo G, Campo S, Arseni B, Carsetti R, Carminati P, De Santis R, Ruggiero V, Sette C.

J Leukoc Biol. 2007 Oct;82(4):801-10. Epub 2007 Jun 4.

PMID:
17548806
33.

[Quality of life and associated clinical distress in fibromyalgia].

Cacace E, Ruggiero V, Anedda C, Denotti A, Minerba L, Perpignano G.

Reumatismo. 2006 Jul-Sep;58(3):226-9. Italian.

34.

Dissecting drug and vehicle metabolic effects in rats by a metabonomic approach.

Colafranceschi M, Capuani G, Miccheli A, Campo S, Valerio M, Tomassini A, Giuliani A, Arseni B, Rossi S, De Santis R, Carminati P, Ruggiero V, Conti F.

J Biochem Biophys Methods. 2007 Apr 10;70(3):355-61. Epub 2006 Aug 30.

PMID:
17011038
35.

Systemic mast cell disease: a rare cause of osteoporosis.

Cacace E, Salis G, Ruggiero V, Perpignano G.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2):210. No abstract available.

PMID:
16762162
36.

Effect of a novel immunosuppressant, ST1959, on the immune system and renal allograft survival in rats.

Pezzotta A, Mister M, Cravedi P, Azzollini N, Cassis L, Ruggiero V, DeSantis R, Carminati P, Remuzzi G, Noris M.

Transplantation. 2005 Jul 27;80(2):231-6.

PMID:
16041268
37.

Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.

Loiarro M, Sette C, Gallo G, Ciacci A, Fantò N, Mastroianni D, Carminati P, Ruggiero V.

J Biol Chem. 2005 Apr 22;280(16):15809-14. Epub 2005 Mar 8.

38.

Markers of bone resorption in bisphosphonate therapy of Paget's disease.

Cacace E, Ruggiero V, Matulli C, Uras L, Perpignano G.

Clin Exp Rheumatol. 2004 Jul-Aug;22(4):502. No abstract available.

PMID:
15301254
39.

Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole in an experimental model of colitis in the rat.

Stasi MA, Ruggiero V, Ursillo A, Taurelli R, Aglianò M, Weber E, Lorenzoni P, Sorrentino V, Pacifici L, Carminati P.

Eur J Pharmacol. 2004 Jun 28;494(2-3):263-72.

PMID:
15212983
40.

Isolation by language and distance in Belgium.

Barrai I, Rodriguez-Larralde A, Manni F, Ruggiero V, Tartari D, Scapoli C.

Ann Hum Genet. 2004 Jan;68(Pt 1):1-16.

41.

In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.

Ruggiero V, Piovesan P, Fabrizi C, Lauro GM, Campo S, Albertoni C, Nucera E, Carminati P, Ghirardi O.

Shock. 2004 Jan;21(1):77-85.

PMID:
14676688
42.

[Safety of lornoxicam in G-6-PDH deficiency].

Perpignano G, Cacace E, Matulli C, Ruggiero V.

Reumatismo. 2003;55(1):45-7. Italian.

43.

T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.

Mohiuddin M, Ruggiero V, Shen Z, DiSesa VJ.

J Thorac Cardiovasc Surg. 1996 Aug;112(2):310-3.

44.

Beneficial effects of a novel platelet-activating factor receptor antagonist, ST 899, on endotoxin-induced shock in mice.

Ruggiero V, Chiapparino C, Manganello S, Pacello L, Foresta P, Martelli EA.

Shock. 1994 Oct;2(4):275-80.

PMID:
7757521
45.

Development of tolerance to experimental cardiac allografts in utero.

Kline GM, Shen Z, Mohiuddin M, Ruggiero V, Rostami S, DiSesa VJ.

Ann Thorac Surg. 1994 Jan;57(1):72-4; discussion 75.

PMID:
8279922
46.

Experiments in cardiac xenotransplantation. Response to intrathymic xenogeneic cells and intravenous cobra venom factor.

Mohiuddin M, Kline G, Shen Z, Ruggiero V, Rostami S, DiSesa VJ.

J Thorac Cardiovasc Surg. 1993 Oct;106(4):632-5.

PMID:
8412256
47.

Successful experimental heart transplantation without immunosuppressive drugs.

Kline GM, Shen Z, Mohiuddin M, Ruggiero V, Rostami S, DiSesa VJ.

J Heart Lung Transplant. 1993 May-Jun;12(3):388-93.

PMID:
8329408
48.

S-adenosylmethionine synthetase in bloodstream Trypanosoma brucei.

Yarlett N, Garofalo J, Goldberg B, Ciminelli MA, Ruggiero V, Sufrin JR, Bacchi CJ.

Biochim Biophys Acta. 1993 Mar 24;1181(1):68-76.

PMID:
8457607
49.

LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives.

Ruggiero V, D'Urso CM, Albertoni C, Campo S, Foresta P, Martelli EA.

Mediators Inflamm. 1993;2(7):S43-50.

50.

In vitro activation of murine peritoneal exudate cells (PEC) and peritoneal macrophages by ST 789.

Foresta P, Ruggiero V, Albertoni C, Pacello L, Leoni B, Arrigoni Martelli E.

Int J Immunopharmacol. 1992 Aug;14(6):1061-8.

PMID:
1428361

Supplemental Content

Loading ...
Support Center